1. Home
  2. ELA vs BIOA Comparison

ELA vs BIOA Comparison

Compare ELA & BIOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELA
  • BIOA
  • Stock Information
  • Founded
  • ELA 1965
  • BIOA 2015
  • Country
  • ELA United States
  • BIOA United States
  • Employees
  • ELA N/A
  • BIOA N/A
  • Industry
  • ELA Consumer Specialties
  • BIOA Biotechnology: Pharmaceutical Preparations
  • Sector
  • ELA Consumer Discretionary
  • BIOA Health Care
  • Exchange
  • ELA Nasdaq
  • BIOA Nasdaq
  • Market Cap
  • ELA 156.2M
  • BIOA 155.6M
  • IPO Year
  • ELA N/A
  • BIOA 2024
  • Fundamental
  • Price
  • ELA $5.76
  • BIOA $4.18
  • Analyst Decision
  • ELA Strong Buy
  • BIOA Hold
  • Analyst Count
  • ELA 1
  • BIOA 4
  • Target Price
  • ELA $9.00
  • BIOA $5.67
  • AVG Volume (30 Days)
  • ELA 69.5K
  • BIOA 463.4K
  • Earning Date
  • ELA 08-06-2025
  • BIOA 08-15-2025
  • Dividend Yield
  • ELA N/A
  • BIOA N/A
  • EPS Growth
  • ELA 15.15
  • BIOA N/A
  • EPS
  • ELA 0.28
  • BIOA N/A
  • Revenue
  • ELA $188,774,278.00
  • BIOA $1,451,000.00
  • Revenue This Year
  • ELA $7.61
  • BIOA N/A
  • Revenue Next Year
  • ELA $6.27
  • BIOA N/A
  • P/E Ratio
  • ELA $21.02
  • BIOA N/A
  • Revenue Growth
  • ELA 14.19
  • BIOA N/A
  • 52 Week Low
  • ELA $4.20
  • BIOA $2.88
  • 52 Week High
  • ELA $7.88
  • BIOA $26.62
  • Technical
  • Relative Strength Index (RSI)
  • ELA 45.44
  • BIOA N/A
  • Support Level
  • ELA $5.68
  • BIOA N/A
  • Resistance Level
  • ELA $6.21
  • BIOA N/A
  • Average True Range (ATR)
  • ELA 0.30
  • BIOA 0.00
  • MACD
  • ELA 0.02
  • BIOA 0.00
  • Stochastic Oscillator
  • ELA 50.61
  • BIOA 0.00

About ELA Envela Corporation

Envela Corp is a provider of recycling and re-commerce services at the forefront of the circular economy. These include re-commercializing luxury hard assets, consumer electronics and IT equipment; and end-of-life recycling solutions. It operates through two segments, Consumer, and Commercial Services. The Consumer segment which generates key revenue for the company predominantly buys to resell or recycle luxury hard assets like jewelry, diamonds, gemstones, fine watches, rare coins and related collectibles, precious-metal bullion products, gold, silver, and other precious metals. The Commercial Services segment provides asset-disposition solutions to government agencies, middle-market firms, corporations, and other organizations.

About BIOA BioAge Labs Inc. Common Stock

Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its focus is metabolic disease, one of the greatest healthcare challenges. The pipeline Products of the company are NLRP3 inhibitors, APJ against, and others.

Share on Social Networks: